Translation in serbian
On Wednesday, March 27, 2019. expert lecture on the topic “Clinical significance of genes FV, FII, MTHFR, PAI-1 and ACE in the choice of Thrombotic Therapy Therapy” was held at the Gemmo Center in cooperation with Makler company.
Prof. Dr. Gorana Mitić, lectured about whether and how different combinations of mutations and the risk of thrombosis that they carry affect the decision on anticoagulant therapy.
Mrs Ivana Buzadžić, a molecular biologist and physiologist, lectured on the importance of molecular markers of hereditary thrombophilia.
Doctors in the field of gynecology, surgery, orthopedics, and hematology supported the activities of the Gemmo Center with professional education as well as a personalized approach to prevention and treatment.